InsiderTradr

FDC Limited (FDC.BO)

BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic

₹353.95 (+2.36%) as of

Key statistics

Market cap
57.63B
P/E (TTM)
19.69
Forward P/E
27.23
EPS (TTM)
17.98
Dividend yield
2.89%
52-week range
314.75 – 473.30
Beta
0.19
Revenue (TTM)
21.9B
Profit margin
13.36%
Volume
118.09k

About FDC Limited

FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastroenterology, ophthalmology, anti-diabetics, cardiovascular care, respiratory care, gynaecology, dermatology, paediatrics, analgesics, vitamins, and nutritional health in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions. It also provides functional food, such as flavoured oral rehydration solution powders, ready-to-drink electrolyte beverages, vitamin-enriched supplements, antioxidant blends and protein-fortified drinks; and various active pharmaceutical ingredients. The company sells its products under the Zifi, Zifi-0, Zocon, Mycoderm, Zathrin, Victofol, Cotaryl, Ziglim-M, Amodep-AT, MumMum 1, Victofol Injection, Simyl MCT, Victofol – C, Electral, and Enerzal brands. It also exports its products to approximately 50 countries. FDC Limited was founded in 1936 and is based in Mumbai, India.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Headquarters
Mumbai, India
Employees
7,076

fdcindia.com

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks